Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain
- 1 February 1992
- journal article
- Published by Elsevier in Brain Research Bulletin
- Vol. 28 (2) , 233-238
- https://doi.org/10.1016/0361-9230(92)90184-y
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The influence of strychnine-insensitive glycine receptor agonists and antagonists on generalized seizure thresholdsBrain Research, 1991
- Kynurenine Pathway Measurements in Huntington's Disease Striatum: Evidence for Reduced Formation of Kynurenic AcidJournal of Neurochemistry, 1990
- Glutamate neurotoxicity and diseases of the nervous systemNeuron, 1988
- Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptorEuropean Journal of Pharmacology, 1988
- Kynurenate and FG9041 have both competitive and non-competitive antagonist actions at excitatory amino acid receptorsEuropean Journal of Pharmacology, 1988
- Identification and measurement of kynurenic acid in the rat brain and other organsAnalytical Biochemistry, 1988
- Kynurenic acid-induced protection of neurochemical and behavioural deficits produced by quinolinic acid injections into the nucleus basalis of ratsNeuroscience Letters, 1986
- Replication of the neurochemical characteristics of Huntington's disease by quinolinic acidNature, 1986
- Fluorometric assay of proteins in the nanogram rangeArchives of Biochemistry and Biophysics, 1973
- ‘Benemid,’ p-(di-n-Propylsulfamyl)-Benzoic Acid: Its Renal Affinity and Its EliminationAmerican Journal of Physiology-Legacy Content, 1951